tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INCY Stock Latest News

Incyte: Genesis Therapeutics to receive $30M upfront in AI collaboration
The FlyIncyte: Genesis Therapeutics to receive $30M upfront in AI collaboration
11d ago
INCY
Incyte’s Strong Q4 Performance and Promising Growth Outlook Earns ‘Buy’ Rating
PremiumRatings
Incyte’s Strong Q4 Performance and Promising Growth Outlook Earns ‘Buy’ Rating
18d ago
INCY
Incyte’s Earnings Call: Robust Growth Amid Challenges
PremiumCompany Announcements
Incyte’s Earnings Call: Robust Growth Amid Challenges
19d ago
INCY
Incyte price target raised to $88 from $86 at TD Cowen
PremiumThe Fly
Incyte price target raised to $88 from $86 at TD Cowen
20d ago
INCY
Incyte price target lowered to $68 from $70 at RBC Capital
PremiumThe Fly
Incyte price target lowered to $68 from $70 at RBC Capital
20d ago
INCY
Incyte Receives Buy Rating Amid Strong Performance and Future Growth Potential
PremiumRatingsIncyte Receives Buy Rating Amid Strong Performance and Future Growth Potential
20d ago
INCY
Incyte price target lowered to $88 from $97 at Citi
Premium
The Fly
Incyte price target lowered to $88 from $97 at Citi
20d ago
INCY
Incyte’s Stock Under Pressure Amid Phase III Data Uncertainty and Conservative 2025 Outlook
Premium
Ratings
Incyte’s Stock Under Pressure Amid Phase III Data Uncertainty and Conservative 2025 Outlook
20d ago
INCY
Incyte’s Strong Growth Prospects and Strategic Positioning Underscore Buy Rating
PremiumRatings
Incyte’s Strong Growth Prospects and Strategic Positioning Underscore Buy Rating
20d ago
INCY
Incyte’s Strong 2024 Financial Performance and Promising Outlook
PremiumCompany Announcements
Incyte’s Strong 2024 Financial Performance and Promising Outlook
20d ago
INCY
Incyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating
PremiumRatings
Incyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating
20d ago
INCY
Closing Bell Movers: Lattice Semi up 13% on earnings
PremiumThe Fly
Closing Bell Movers: Lattice Semi up 13% on earnings
20d ago
ACLS
ALAB
Incyte terminates license agreement with Agenus
PremiumThe FlyIncyte terminates license agreement with Agenus
20d ago
AGEN
INCY
Incyte files to sell 30.49M shares of common stock for holders
Premium
The Fly
Incyte files to sell 30.49M shares of common stock for holders
20d ago
INCY
Incyte price target raised to $77 from $75 at Stifel
Premium
The Fly
Incyte price target raised to $77 from $75 at Stifel
20d ago
INCY
Incyte reports Q4 EPS $1.46, consensus $1.55
PremiumThe Fly
Incyte reports Q4 EPS $1.46, consensus $1.55
21d ago
INCY
Options Volatility and Implied Earnings Moves Today, February 10, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, February 10, 2025
21d ago
ON
MCD
Incyte (INCY) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Incyte (INCY) Q4 Earnings Cheat Sheet
23d ago
INCY
Incyte, Syndax announce FDA approval for Niktimvo vial sizes
PremiumThe Fly
Incyte, Syndax announce FDA approval for Niktimvo vial sizes
2M ago
INCY
SNDX
Incyte Announces Retirement of Executive VP Barry Flannelly
PremiumCompany AnnouncementsIncyte Announces Retirement of Executive VP Barry Flannelly
2M ago
8K
INCY
Early notable gainers among liquid option names on January 7th
Premium
The Fly
Early notable gainers among liquid option names on January 7th
2M ago
MU
WBA
Incyte price target raised to $75 from $74 at RBC Capital
Premium
The Fly
Incyte price target raised to $75 from $74 at RBC Capital
2M ago
INCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >